General Information
Drug ID
DR00390
Drug Name
Fluvoxamine
Synonyms
(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine; 2-[({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine; Dumirox; Dumyrox; Faverin; Floxyfral; Fluvoxamina; Fluvoxamina [INN-Spanish]; Fluvoxamine (INN); Fluvoxamine [INN:BAN]; Fluvoxamine-CR; Fluvoxaminum; Fluvoxaminum [INN-Latin]; Luvox (TN); Maveral
Drug Type
Small molecular drug
Indication Obsessive compulsive disorder [ICD11: 6B20] Approved [1]
Therapeutic Class
Antidepressants
Structure
3D MOL 2D MOL
Formula
C15H21F3N2O2
Canonical SMILES
COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
InChI
InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+
InChIKey
CJOFXWAVKWHTFT-XSFVSMFZSA-N
CAS Number
CAS 54739-18-3
Pharmaceutical Properties Molecular Weight 318.33 Topological Polar Surface Area 56.8
Heavy Atom Count 22 Rotatable Bond Count 9
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 7
XLogP
2.6
PubChem CID
5324346
PubChem SID
103112227 , 103214033 , 103937470 , 114182507 , 11571264 , 117504588 , 124749760 , 124883444 , 124883445 , 124883446 , 126628425 , 126651435 , 126666543 , 131318468 , 134338027 , 134339778 , 135004455 , 137002947 , 139157656 , 143472592 , 144204388 , 14899201 , 160963524 , 162182990 , 163392547 , 163842794 , 164841793 , 164841794 , 17425133 , 26751469 , 39297346 , 47276707 , 47350437 , 47425375 , 48020069 , 48020070 , 49699379 , 50002999 , 50103976 , 51005940 , 57361188 , 7979296 , 85788587 , 90340960 , 92718857 , 93166767 , 93310594 , 96024678 , 9774 , 99373241
ChEBI ID
ChEBI:5138
TTD Drug ID
D03HFG
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Fluvoxamine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. J Pharm Pharmacol. 2004 Aug;56(8):967-75.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.